Please turn JavaScript on
Find more feeds
Labiotech.eu icon

Labiotech.eu

Subscribe to Labiotech.eu’s news feed.

Click on “Follow” and decide if you want to get news from Labiotech.eu via RSS, as email newsletter, via mobile or on your personal news page.

Subscription to Labiotech.eu comes without risk as you can unsubscribe instantly at any time.

You can also filter the feed to your needs via topics and keywords so that you only receive the news from Labiotech.eu which you are really interested in. Click on the blue “Filter” button below to get started.

Title: Labiotech.eu

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.89 / day

Message History

Highlights of ASCO 2026: how is cancer care evolving? 

Labiotech heard from experts about the major trends and highlights in cancer care at ASCO 2026.

The post Highlights of ASCO 2026: how is cancer care evolving?  appeared first on


Read full story
Surge in M&As driven by patent expirations 

We look at how rising acquisitions in the life science industry are being driven by patent cliffs. 

The post Surge in M&As driven by patent expirations  appeared first on


Read full story
The biggest biotech funding rounds in May 2026

Isomorphic Labs, Apogee Therapeutics, and Avalo Therapeutics bagged the biggest biotech funding rounds overall in May 2026.

The post The biggest biotech funding rounds in May 2026 appeared first on


Read full story
What China’s new CGT rules mean for biotech business 

Explore the future of cell and gene therapies in China as it adopts a new piece of regulation that might change strategies.

The post What China’s new CGT rules mean for biotech business  appeared first on


Read full story
Can WEE1 inhibitors finally make replication stress druggable? 

Find out about how biotech companies are trying to address the limits the first generation of WEE1 inhibitors faced.

The post Can WEE1 inhibitors finally make replication stress druggable?  appeared first on


Read full story